Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P1063: Comparison of all paediatric patients and young adults with Crohn’s Disease treated with ustekinumab in the REALITI Real-World Evidence Effectiveness StudyECCO'24
Year: 2024
Authors: Shehzad, S.(1)*;Steiner, S.(2);Adler, J.(3);Colletti, R.B.(4);Strauss, R.(5);Heile, J.(6);Adedokun, O.(7);Sheahan, A.(8);Zhang, R.(9);Lo, K.H.(10);Kim, L.(10);Xiao, Y.(11);Volger, S.(5);
(1)Dayton Children@E@s Hospital/Wright State University, Clinically Integrated Network, Dayton, United States;(2)Riley Hospital for Children- Indiana University School of Medicine, Pediatric Gastroenterology- Hepatology and Nutrition, Indianapolis, United States;(3)University of Michigan, Pediatric Gastroenterology Clinic, Ann Arbor, United States;(4)University of Vermont Children@E@s Hospital, Pediatrics, Burlington, United States;(5)Janssen Research & Development- LLC, Pediatric Development Team, Spring House, United States;(6)Cilag GmbH International, Global Regulatory Affairs, Zug, United States;(7)Janssen Research & Development- LLC, Global Clinical Pharmacology & Pharmacometrics, Spring House, United States;(8)Janssen Research & Development- LLC, Immunology Epidemiology, Titusville, United States;(9)Janssen Research & Development- LLC, CA Data Analysis, San Diego, United States;(10)Janssen Research & Development- LLC, Statistics and Decision Sciences, Spring House, United States;(11)Cytel, Statistics, Waltham, United States;
P1064: Upadacitinib is safe and effective in Ulcerative Colitis patients with prior exposure to TofacitinibECCO'24
Year: 2024
Authors: Gilmore, R.(1,2)*;Fernandes, R.(1,2);Hartley, I.(3);Arzivian, A.(4);Leong, R.(4);Andrew, B.(5);Vasudevan, A.(5);Greeve, T.(6);Moore, G.(6);Kim, S.(7);Lightowler, D.(8);Singh, A.(7);Mahy, G.(9);Mithanthaya, A.(10);Venugpal, K.(10);Han, S.(11);Bryant, R.(11);West, J.(12);Segal, J.(12);Christensen, B.(12);Ding, N.J.(3);An, Y.K.(1,2);Begun, J.(1,2);
(1)Mater Hospital, Department of Gastroenterology, Brisbane, Australia;(2)Mater Research Institute, University of Queensland, Brisbane, Australia;(3)St Vincent@E@s Hospital, Department of Gastroenterology, Melbourne, Australia;(4)Macquarie University Hospital, Department of Gastroenterology, Sydney, Australia;(5)Eastern Health, Department of Gastroenterology, Melbourne, Australia;(6)Monash Health, Department of Gastroenterology, Melbourne, Australia;(7)Fiona Stanley Hospital, Department of Gastroenterology, Perth, Australia;(8)Wexford Gastroenterology, Department of Gastroenterology, Perth, Australia;(9)Townsville University Hospital, Department of Gastroenterology, Townsville, Australia;(10)Royal Perth Hospital, Department of Gastroenterology, Perth, Australia;(11)The Queen Elizabeth Hospital, Department of Gastroenterology, Adelaide, Australia;(12)Royal Melbourne Hospital, Department of Gastroenterology, Melbourne, Australia;
P1065: Endoscopic Submucosal Dissection for High-Risk Colorectal Colitis-Associated Neoplasia in Inflammatory Bowel Disease: a Real-World Multicenter StudyECCO'24
Year: 2024
Authors: Maselli, R.(1);de Sire, R.(1)*;Barbaro, F.(2);Cecinato, P.(3);Andrisani, G.(4);Rosa Rizzotto, E.(5);Sferrazza, S.(6);Fiori, G.(7);Azzolini, F.(8);Pugliese, F.(9);Facciorusso, A.(10);Repici, A.(1);Armuzzi, A.(11);
(1)Humanitas Research Hospital- IRCCS, Gastroenterology- Endoscopy Unit, Rozzano, Italy;(2)Fondazione Policlinico Universitario Agostino Gemelli- IRCCS, Digestive Endoscopy Unit, Rome, Italy;(3)Azienda USL di Reggio Emilia- IRCCS, Gastroenterology and Digestive Endoscopy, Reggio Emilia, Italy;(4)Campus Bio-Medico- University of Rome, Digestive Endoscopy Unit, Rome, Italy;(5)St. Anthony Hospital- Azienda Ospedale-Università, Gastroenterology Unit, Padua, Italy;(6)Presidio Ospedaliero Santa Chiara- Trento, Gastroenterology and Digestive Endoscopy Unit, Trento, Italy;(7)Istituto Europeo di Oncologia- IRCCS, Endoscopy Unit, Milan, Italy;(8)San Raffaele Scientific Institute- IRCCS, Gastroenterology and Gastrointestinal Endoscopy Unit, Milan, Italy;(9)Niguarda-Ca@E@ Granda Hospital, Digestive and Interventional Endoscopy Unit, Milan, Italy;(10)University of Foggia, Gastroenterology Unit, Foggia, Italy;(11)Humanitas Research Hospital- IRCCS, Gastroenterology- IBD Unit, Rozzano, Italy;on behalf of Endoscopic Resection Italian Network (ERIN) Group
P1066: The real-life use of the Crohn@E@s disease exclusion diet (CDED) in adults with mild-to-moderate Crohn@E@s disease activity: an interim analysis of an open-label randomized controlled trialECCO'24
Year: 2024
Authors: Bodini, G.(1);Pasta, A.(1)*;Formisano, E.(2);Calabrese, F.(1);Apollonio, M.(2);Pisciotta, L.(2);Giannini, E.G.(1);
(1)Gastroenterology Unit, Department of Internal Medicine- University of Genoa, Genoa, Italy;(2)Dietetics and Clinical Nutrition Unit, Department of Internal Medicine- University of Genoa, Genoa, Italy;
P1067: Pan-enteric mucosal inflammation in CD patients treated with vedolizumab assessed by capsule endoscopy– interim results of a prospective observational studyECCO'24
Year: 2024
Authors: Ukashi, O.(1,2)*;Lahat, A.(1,2);Ungar, B.(1,2);Levy , H.(1,2);Eidler , P.(1);Ben-Horin, S.(1,2);Eliakim, R.(1,2);Kopylov, U.(1,2);
(1)Sheba Medical Center Tel Hashomer, Gastroenterology Institute, Ramat gan, Israel;(2)Tel-Aviv University, School of Medicine, Tel-aviv, Israel;
P1068: Limited long-term efficacy of corticosteroids in microscopic colitis emphasizing the need for advanced therapiesECCO'24
Year: 2024
Authors: Taelman, T.(1)*;Vermeire, S.(2);Ferrante, M.(2);Sabino, J.(2);Verstockt, B.(2);
(1)UZ Leuven, Department of Gastroenterology and Hepatology- University Hospitals Leuven- KU Leuven- Leuven- Belgium., Leuven, Belgium;(2)Uz Leuven, Department of Gastroenterology and Hepatology- University Hospitals Leuven- KU Leuven- Leuven- Belgium. Translational Research in Gastrointestinal Disorders- Department of Chronic Diseases and Metabolism CHROMETA- KU Leuven- Leuven- Belgium., Leuven, Belgium;
P1069: One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort studyECCO'24
Year: 2024
Authors: Bae, J.H.(1);Park, J.B.(1);Baek, J.E.(1);Lee, Y.J.(2,3);Kim, K.O.(3,4);Kim, E.S.(3,5);Jo, H.H.(3,6);Hong, S.W.(1);Park, S.H.(1,7);Yang, D.H.(1);Ye, B.D.(1,7);Byeon, J.S.(1);Myung, S.J.(1);Yang, S.K.(1,7);Kim, E.Y.(3,6);Hwang, S.W.(1,7)*;
(1)University of Ulsan College of Medicine- Asan Medical Center, Department of Gastroenterology and Internal medicine, Seoul, Korea- Republic Of;(2)Keimyung University School of Medicine, Department of Internal medicine, Daegu, Korea- Republic Of;(3)Crohn’s and Colitis Association in Daegu-Gyeongbuk, CCAiD, Daegu, Korea- Republic Of;(4)Yeungnam University College of Medicine, Department of Internal medicine, Daegu, Korea- Republic Of;(5)Kyungpook National University School of Medicine, Department of Internal medicine, Daegu, Korea- Republic Of;(6)Daegu Catholic University School of Medicine, Department of Internal medicine, Daegu, Korea- Republic Of;(7)University of Ulsan College of Medicine- Asan Medical Center, Inflammatory Bowel Disease Center, Seoul, Korea- Republic Of;
P106: Single-cell transcriptomic analysis reveals insights into the mechanism of action of Granulocyte-monocyte apheresisECCO'24
Year: 2024
Authors: Kioroglou, D.(1);Cabriada, J.L.(2);Martinez Marigorta, U.(1)*;Rodriguez-Lago, I.(2);
(1)CIC bioGUNE, Integrative Genomics Lab, Derio, Spain;(2)Hospital Universitario de Galdakao, Gastroenterology Department, Galdakao, Spain;
P1070: Utilization of HLA-DQA1*05 haplotype testing in routine clinical practice to stratify advanced therapies: A prospective pilot studyECCO'24
Year: 2024
Authors: Ibrahim, F.A.E.(1)*;Aleman Gonzalez, H.(1);Whitehead, E.(1);Robertson, H.(1);Fitzgerald, A.L.(1);Turnbull, J.(1);Messiha, M.(1);Thomas, M.(1);Sebastian, S.(1);
(1)Hull University Teaching Hospitals NHS Trust, Gastroenterology, Hull, United Kingdom;
P1071: Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAIDECCO'24
Year: 2024
Authors: Caron, B.(1)*;Seksik, P.(2);Buisson, A.(3);Wils, P.(4);Savoye, G.(5);Stefanescu, C.(6);Laharie, D.(7);Guillo, L.(8);Abitbol, V.(9);Bonnet, J.(10);Altwegg, R.(11);Vuitton, L.(12);Moussata, D.(13);Bourreille, A.(14);Biron, A.(15);Gilletta, C.(16);Fumery, M.(17);Nahon, S.(18);Nancey, S.(19);Camara, H.(20);Peyrin-Biroulet, L.(1);
(1)Nancy University Hospital, Gastroenterology, Nancy, France;(2)Hôpital Saint-Antoine, Gastroenterology, Paris, France;(3)CHU Clermont-Ferrand, Gastroenterology, Clermont-Ferrand, France;(4)CHU Lille, Gastroenterology, Lille, France;(5)Rouen University Hospital, Gastroenterology, Rouen, France;(6)Paris IBD Center, Gastroenterology, Neuilly sur Seine, France;(7)CHU de Bordeaux, Gastroenterology, Bordeaux, France;(8)University Hospital of Marseille Nord, Gastroenterology, Marseille, France;(9)Cochin University Hospital, Gastroenterology, Paris, France;(10)Hôpital Saint-Louis/Lariboisière, Gastroenterology, Paris, France;(11)University Hospital of Montpellier, Gastroenterology, Montpellier, France;(12)Besançon University Hospital, Gastroenterology, Besançon, France;(13)University Hospital of Tours, Gastroenterology, Tours, France;(14)CHU Nantes, Gastroenterology, Nantes, France;(15)Reims University Hospital, Gastroenterology, Reims, France;(16)Toulouse University Hospital, Gastroenterology, Toulouse, France;(17)Amiens University Hospital, Gastroenterology, Amiens, France;(18)Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Gastroenterology, Montfermeil, France;(19)Hospices Civils de Lyon, Gastroenterology, Lyon, France;(20)Nancy University Hospital, Methodology- data management and statistic, Nancy, France;GETAID PREFERADA study group
P1072: Upadacitinib appears effective in inducing clinical, biochemical, endoscopic and histologic improvements in previously treatment refractory Ulcerative ColitisECCO'24
Year: 2024
Authors: Choon, X.Y.(1)*;Patel, C.(1);White, C.(1);Centritto, A.(1);Lal, N.(1);Sharma, E.(1);Chester, D.(1);Dart, R.(1);Anderson, S.(1);Ray, S.(1);Mawdsley, J.(1);Irving, P.(1);Samaan, M.(1);
(1)Guy@E@s and St Thomas@E@ NHS Foundation Trust, Gastroenterology, London, United Kingdom;
P1073: Opioid use Before and After First Diagnosis of Crohn’s Disease: A Swedish Nationwide Cohort Study 2008-2020ECCO'24
Year: 2024
Authors: Osooli, M.(1)*;Bruze, G.(1);Bryder, N.(1);Nordenvall, C.(2,3);Myrelid, P.(4,5);Everhov, Å.H.(1,6);Olén, O.(1,6,7);
(1)Karolinska Institutet, Division of Clinical Epidemiology- Department of Medicine Solna, Stockholm, Sweden;(2)Karolinska University Hospital, Department of Molecular Medicine and Surgery, Stockholm, Sweden;(3)Karolinska University Hospital, Department of Pelvic Cancer- Unit of IBD-surgery, Stockholm, Sweden;(4)Linköping University Hospital, Department of Surgery, Linköping, Sweden;(5)Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden;(6)Karolinska Institutet, Department of Clinical Science and Education Södersjukhuset, Stockholm, Sweden;(7)Stockholm South General Hospital, Sachs’ Children and Youth Hospital, Stockholm, Sweden;
P1074: Impact of body mass index (BMI) on clinical outcomes and drug levels in patients with Crohn’s disease receiving maintenance treatment with subcutaneous infliximab: A post hoc analysis of the LIBERTY-CD studyECCO'24
Year: 2024
Authors: Yarur, A.(1);Hanauer, S.B.(2);Schreiber, S.(3);Colombel, J.F.(4);Deepak, P.(5);Jeong, A.L.(6);Kim, D.H.(6);Lee, Y.N.(6);Danese, S.(7)*;
(1)Cedars Sinai Medical Center, F. Widjaja Inflammatory Bowel Disease Institute, Los Angeles, United States;(2)Northwestern University- Feinberg School of Medicine, Division of Gastroenterology and Hepatology- Department of Medicine, Chicago, United States;(3)University Hospital Schleswig-Holstein, Department of Medicine I, Kiel, Germany;(4)Icahn School of Medicine at Mount Sinai, Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States;(5)Washington University in St. Louis School of Medicine, Division of Gastroenterology, St. Louis, United States;(6)Celltrion Healthcare Co.- Ltd, Not applicable, Incheon, Korea- Republic Of;(7)IRCCS San Raffaele Hospital and Vita-Salute University, Department of Gastroenterology, Milan, Italy;
P1075: Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric studyECCO'24
Year: 2024
Authors: Monin, L.(1)*;Reenaers, C.(1);Grandfils, S.(2);Latour, P.(1);Van Kemseke, C.(1);Kropp, S.(1);Louis, E.(1);Vieujean, S.(1);
(1)University Hospital CHU of Liège, Hepato-Gastroenterology and Digestive Oncology, Liège, Belgium;(2)University Hospital CHU of Liège, Gynecology and Obstetrics, Liège, Belgium;
P1077: Patients’ and Gastroenterologists’ Preferences on Outcomes and Medication Attributes for Ulcerative colitisECCO'24
Year: 2024
Authors: Katsoula, A.(1,2)*;Paschos, P.(2,3);Giouleme, O.(1);Toumbalidou, M.(2);Mainou, M.(2,4);Malandris, K.(2);Tsapas, A.(2,4,5);
(1)Hippokration Hospital, Gastroenterology Division-Second Propaedeutic Department of Internal Medicine - Medical School - Aristotle University of Thessaloniki, Thessaloniki, Greece;(2)Clinical Research and Evidence-Based Medicine Unit, Second Medical Department- Aristotle University of Thessaloniki, Thessaloniki, Greece;(3)First Department of Internal Medicine, “Papageorgiou” Hospital, Thessaloniki, Greece;(4)Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;(5)Harris Manchester College, University of Oxford, Oxford, United Kingdom;This study was funded by a research grant 2020EOMIFNEp5 from the Hellenic Group for the Study of IBD (EOMIFNE)
P1078: The influence of different 5-aminosalicylic acid preparations on mercaptopurine metabolismECCO'24
Year: 2024
Authors: AnjieMD, S.(1)*;Hettinga, J.(1);Volkers, A.G.(1);van Gennep, S.(1);Clasquin, E.(1);Duijvestein, M.(2);van Bodegraven, A.A.(3);van der Zanden, E.P.(4);Jansen, J.M.(5);van Asseldonk, D.P.(6);West, R.L.(7);D@E@Haens, G.R.A.M.(1);Löwenberg, M.(1);de Boer, N.K.(8);
(1)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Radboudumc, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(3)Zuyderland, Department of Gastroenterology and Hepatology, Sittard-Geleen, The Netherlands;(4)Ziekenhuis Amstelland, Department of Gastroenterology and Hepatology, Amstelveen, The Netherlands;(5)OLVG, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)Noordwest Ziekenhuisgroep, Department of Gastroenterology and Hepatology, Alkmaar, The Netherlands;(7)Franciscus Gasthuis, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(8)Amsterdam Gastroenterology Endocrinology Metabolism Research Institute- Amsterdam University Medical Centre- Vrije Universiteit Amsterdam- Amsterdam- The Netherlands, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;
P1079: Mindfulness-based cognitive therapy to reduce psychological distress in patients with Inflammatory Bowel Disease: first results of a multicentre randomised controlled trial (MindIBD).ECCO'24
Year: 2024
Authors: Ter Avest, M.(1,2,3)*;Speckens, A.(1,3);Dijkstra, G.(4);Dresler, M.(3);Bosman, S.(1,3);Horjus, C.(5);Römkens, T.(2);Witteman, E.(6);Van Dop, W.(7);Nissen, L.(2);Huijbers, M.(1);
(1)Radboud University Medical Centre, Department of Psychiatry- Centre for Mindfulness, Nijmegen, The Netherlands;(2)Jeroen Bosch Hospital, Department of Gastroenterology and Hepatology, @E@s-Hertogenbosch, The Netherlands;(3)Radboud University Medical Centre, Donders Institute for Brain- Cognition and Behaviour, Nijmegen, The Netherlands;(4)University Medical Centre Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(5)Rijnstate Hospital, Department of Gastroenterology and Hepatology, Arnhem, The Netherlands;(6)Canisius Wilhelmina Hospital, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(7)Radboud University Medical Centre, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;
P107: Comparing the Colonic Tissue Proteome of Active and Inactive Ulcerative ColitisECCO'24
Year: 2024
Authors: Penner, R.(1)*;de Almeida, L.(2);Rosentreter, R.(3);Hirota, S.(4);Dufour, A.(2);Lu, C.(1);
(1)University of Calgary, Division of Gastroenterology and Hepatology- Department of Medicine- University of Calgary, Calgary, Canada;(2)University of Calgary, Department of Biochemistry and Molecular Biology- University of Calgary- Alberta, Calgary, Canada;(3)University of Calgary, Division of Gastroenterology and Hepatology- Department of Medicine- University of Calgary1, Calagary, Canada;(4)University of Calgary, Department of Physiology & Pharmacology- University of Calgary- Alberta, Calgary, Canada;
P1080: Real-world Study on Early Predictors of Infliximab Treatment Efficacy in Crohn@E@s diseaseECCO'24
Year: 2024
Authors: Lv, C.(1)*;Chen, Y.(2);Yan, F.(3);Pi, S.(2);Liu, Y.(2);Chen, R.(1);Tang, W.(1);Zhang, H.(3);
(1)The Second Affiliated Hospital of Soochow University, Gastroenterology, Suzhou, China;(2)Suzhou Medical College of Soochow University, Pathology- School of Biology and Basic Medical Sciences, Suzhou, China;(3)The First Affiliated Hospital of Nanjing Medical University, Gastroenterology, Nanjing, China;
P1081: Pharmacokinetics and immunogenicity of the ustekinumab biosimilar candidate ABP 654 in patients with moderate-to-severe plaque psoriasisECCO'24
Year: 2024
Authors: Chow, V.(1)*;Mytych, D.T.(1);Blauvelt, A.(2);Papp, K.(3);Barragan, C.(1);Yamauchi, P.(4);Crowley, J.(5);Franklin, J.(1);
(1)Amgen Inc, Biosimilars Business Unit, Thousand Oaks, United States;(2)Oregon Medical Research Center, Oregon Medical Research Center, Portland, United States;(3)Alliance Clinical Trials Probity Medical Research, Alliance Clinical Trials Probity Medical Research, Waterloo, Canada;(4)Dermatology Institute & Skin Care Center- Inc., Clinical Science Institute, Santa Monica, United States;(5)Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, United States;